Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Technology Information Technology Services

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by u2bobon Sep 02, 2017 12:49pm

171 Views

Post# 26650653

RE:New chef medical absolutely competent

Sh99999 wrote:

DR. HADI CHAKOR – CHEF MDICAL
Hadi Chakor

Executive Director of Diagnos Algeria, DIAGNOS Inc.

Diagnos Mdical Algerie

ISCEV (International Society for Clinical Elec.

Professional expertise:
- Author of a new retinal microvascular score to quantify the risk of the cardiovascular disease. Investigating the association between the prevalence of cardiovascular disease and descriptors of the retinal microvasculature in a high-risk population and nomal risk by new biomarkers of micro-vascularisation vessels.
- Doctor (MD) and Certified Clinical Visual Electrophysiologist Specialist (ISCEV certification).
- Senior Research consultant and Senior Clinical Project Manager at Institut national d’excellence en sant et en services sociaux (INESSS).
- Senior Clincial Scientist at Montreal Heart Institute (MHI).
- Senior Research Associate and Co investigator, at Ophthalmology department, Clinique Michel POP 2004-2006.
- Research Assistant, Ophthalmology Department, Montreal Children’s Hospital 2003-2004.
- Responsibilities include: Research design, author of several protocols, supervision of junior staff, monitoring and implementation of research protocols, statistical analysis, and technical writing.
- More than 10 years of experience in clinical and fundamental research.
- Co investigator in charge of a major research project involving Health Canada and the FDA.
- GCP and ICH knowledge (certification).
- expert in retinal vascularization, visual electrophysiology and microvascular atherosclerosis,
- Excellent writing and oral communication skills (articles and protocols).
- Up-to-date in medical literature.
- Conduct fundamental and clinical projects in cardiology: Coronary Heart Disease (CHD).
Visual Electrophysiologist:
Performed mfERGs (multifocal electroretinograms) and mfVEPs (multifocal visual evoked potentials)
DR. HADI CHAKOR
it will advance in the near future:(FL AIRE is a powerful AI engine that provides the capability of analyzing large and complex data sets.

ADK is heading in the right direction...even if the stock price does not reflect it yet !

Company already has a... CLOUD BASE ...DATA...

Deep Learning ...FLAIRE..

Diabetic eye scan...CARA...

Cardio...RD..being developing...

Mining ...AI CARDS SOLD...investment with royalties attached...

DTC ...OTCQB ...US Investors...Trading under 10 cents US is crazy !

Contracts...Pilot projects...Sales...

IMHO...company is heading in the right direction when I read statements like the one below...from another site...share price is frustrating ...lets hope the company has the right plan to get us all there...adding data has plenty of value for us as we look to expand in other fields...

(Remember how we talked about how important data is?) Instead of specializing in one particular area, they want to be generalists across multiple areas like these: